Draw conclusions from dormant drug approvals

“The current incident is ultimately a consequence of advanced globalization in the field of drug development and production. This globalization has created a new level of confusion. The consequences of this lack of clarity not only cause uncertainty for patients. They are also and especially completely unsatisfactory for the pharmacies, which are responsible for a safe and high-quality supply of medicines. They now have to shoulder additional administrative burdens and deal with legal imponderables and economic risks if they want to provide patients with alternatives to the drugs whose approval is suspended.